Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
Leukemia|May 13, 2020
Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemiaArnon Nagler, Bhagirathbhai Dholaria, Myriam Labopin, et al.
Blood Neoplasia|April 6, 2026
Late outcomes after posttransplant cyclophosphamide-based GVHD prophylaxis in patients with AML: an ALWP-EBMT studyEduardo Rodríguez-Arbolí, Allain-Thibeault Ferhat, Anna Maria Raiola, et al.
Clinical Genitourinary Cancer|July 23, 2016
Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012Andrea Necchi, Salvatore Lo Vullo, Marco Bregni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 4, 2021
Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experienceBarbara Loteta, Annalisa Paviglianiti, Virginia Naso, et al.
Cancers|October 16, 2024
First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center StudyMassimo Martino, Mercedes Gori, Gaetana Porto, et al.
Annals of Hematology|April 20, 2023
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantationMassimo Martino, Mercedes Gori, Gaetana Porto, et al.
Transplantation and Cellular Therapy|May 12, 2026
Fludarabine-Treosulfan (FT10) Conditioning in Older AML Patients Undergoing Haploidentical Transplantation: A Prospective Italian Study with External Comparison to the Haplo-UK Reduced-Intensity Conditioning CohortVincenzo Federico, Daniele Avenoso, Kavita Raj, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2026
Outcomes of CAR T-Cell Therapy in transformed indolent Non-Hodgkin Lymphomas and de novo DLBCL: A comparative analysis from the Italian CAR T-SIE studyNicole Fabbri, Beatrice Casadei, Annalisa Chiappella, et al.
British Journal of Haematology|December 23, 2024
Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE studyFederico Stella, Annalisa Chiappella, Martina Magni, et al.
Bone Marrow Transplantation|March 24, 2020
Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-BegelomabAndrea Bacigalupo, Emanuele Angelucci, Anna Maria Raiola, et al.
Pageof 17